Intraarticular Glucocorticoid Injection as Second-line Treatment for Lyme Arthritis in Children
نویسندگان
چکیده
منابع مشابه
Dapsone as a second glucocorticoid-sparing agent in addition to azathioprine in treatment of pemphigus vulgaris
Background and aim: Pemphigus vulgaris is an autoimmune vesiculobullous disorder. Prior to the advent of glucocorticoid therapy, it was often fatal. Now its mortality and morbidity is due to highdose glucocorticoid complications rather than the disease itself. This study was aimed to determine the effect of dapsone as a second adjuvant in the treatment of pemphigus vulgaris.Materials and method...
متن کاملAnakinra for systemic onset juvenile idiopathic arthritis: experience as a second versus first line treatment
Results Among 23 patients treated with Anakinra, in 3 (13%) patients it has been used as a first-line drug without corticosteroids (group A), in 5 (22%) as a first-line with corticosteroids (group B) and in 15 (65%) patients Anakinra was used as a second-line treatment when others DMARDs failed to control the disease (group C). There were no statistical differences in sex, age of diagnose of So...
متن کاملIntraarticular injection of infliximab.
3. Information on permissions/orders of reprints in rheumatology and related fields. Silverman featuring research articles on clinical subjects from scientists working is a monthly international serial edited by Earl D.
متن کاملCombination second-line therapy for rheumatoid arthritis.
WHILE the treatment of RA has become more aggressive in recent years by the earlier use of second-line agents, remissions, as measured by the ACR [1], resulting from these therapies are rare. Concern has been expressed that the mortality risk in patients with RA is similar to that seen in Stage IV Hodgkin's disease or three vessel coronary artery disease [2]. Certainly, the consideration of dis...
متن کاملGlucocorticoid treatment in early rheumatoid arthritis.
Glucocorticoids (GCs) have been an invaluable tool in the treatment of patients with rheumatoid arthritis (RA) for decades, with a focus mainly on symptom management. In addition, several studies in the last 15 years have shown that GCs are also disease-modifying in patients with RA - which implies that they inhibit radiographic progression. These effects seem to be especially important in the ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Rheumatology
سال: 2019
ISSN: 0315-162X,1499-2752
DOI: 10.3899/jrheum.180829